# EWAS-Lewy_body_dementia

This study investigated DNA methylation modulations in Dementia with Lewy bodies cases and neurologically healthy controls.
The code describes the steps necessary to perform QC and data processing.
The outputs of the EWAS include differentially methylated probes and regions, and a functional enrichment analysis.

Pubmed: https://pubmed.ncbi.nlm.nih.gov/38182665/

Corresponding author: Sonja W. Scholz, M.D., Ph.D., Neurodegenerative Diseases Research Unit, National Institutes of Health | NINDS, Bethesda, MD 20892-3707, USA. | Email: sonja.scholz@nih.gov

First author: Paolo Reho, Ph.D., Neurodegenerative Diseases Research Unit, National Institutes of Health | NINDS, Bethesda, MD 20892-3707, USA. | Email: paolo.reho@nih.gov
